Sotera Health Company $SHC Stock Holdings Increased by Legal & General Group Plc

Legal & General Group Plc increased its holdings in Sotera Health Company (NASDAQ:SHC) by 20.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 308,389 shares of the company’s stock after purchasing an additional 52,863 shares during the quarter. Legal & General Group Plc owned 0.11% of Sotera Health worth $5,440,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. IFP Advisors Inc raised its holdings in shares of Sotera Health by 1,105.6% in the 4th quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after purchasing an additional 1,371 shares in the last quarter. True Wealth Design LLC raised its holdings in shares of Sotera Health by 389.3% in the 4th quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock worth $32,000 after purchasing an additional 1,456 shares in the last quarter. Allworth Financial LP raised its holdings in shares of Sotera Health by 922.0% during the fourth quarter. Allworth Financial LP now owns 3,025 shares of the company’s stock valued at $53,000 after acquiring an additional 2,729 shares during the period. EverSource Wealth Advisors LLC raised its holdings in shares of Sotera Health by 831.4% during the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock valued at $37,000 after acquiring an additional 2,935 shares during the period. Finally, GAMMA Investing LLC raised its holdings in shares of Sotera Health by 31.1% during the fourth quarter. GAMMA Investing LLC now owns 4,892 shares of the company’s stock valued at $86,000 after acquiring an additional 1,161 shares during the period. 91.03% of the stock is currently owned by institutional investors.

Sotera Health Stock Performance

Shares of SHC opened at $15.62 on Monday. The company’s 50 day moving average price is $15.37 and its 200 day moving average price is $16.37. Sotera Health Company has a 52 week low of $10.80 and a 52 week high of $19.85. The company has a market capitalization of $4.45 billion, a PE ratio of 38.10 and a beta of 1.79. The company has a debt-to-equity ratio of 3.56, a quick ratio of 2.54 and a current ratio of 2.82.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. The firm had revenue of $280.05 million for the quarter, compared to the consensus estimate of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The firm’s revenue was up 10.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Research analysts expect that Sotera Health Company will post 0.86 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on SHC. Wall Street Zen lowered shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Weiss Ratings lowered shares of Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Thursday, May 21st. Barclays cut their price target on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Citigroup boosted their price target on shares of Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a report on Tuesday, February 24th. Finally, The Goldman Sachs Group began coverage on shares of Sotera Health in a report on Friday. They set a “buy” rating and a $20.00 price target on the stock. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $20.29.

Insider Buying and Selling

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the business’s stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total value of $193,194,516.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 15.36% of the stock is owned by corporate insiders.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.